Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BL-B01D1

Catalog No. T9901A-487 Copy Product Info
🥰Excellent
BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.

BL-B01D1

Copy Product Info
🥰Excellent
Catalog No. T9901A-487

BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.

BL-B01D1
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$1,2206-8 weeks6-8 weeks
5 mg$3,6186-8 weeks6-8 weeks
10 mgInquiry6-8 weeks6-8 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy BL-B01D1 | purchase BL-B01D1 | BL-B01D1 cost | order BL-B01D1